Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency-Reference-Cited by-同舟云学术

Fluvastatin improves lipid abnormalities in patients with moderate to advanced chronic renal insufficiency

Published:2002-01 Issue:1 Volume:39 Page:67-75
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Samuelsson Ola,Attman Per-Ola,Knight-Gibson Carolyn,Mulec Henrik,Weiss Lars,Alaupovic Petar

Publisher

Elsevier BV

Subject

Nephrology

Reference57 articles.

1. Lipoprotein metabolism and renal failure;Attman;Am J Kidney Dis,1993

2. Lipoprotein abnormalities without hyperlipidemia in moderate renal insufficiency;Samuelsson;Nephrol Dial Transplant,1994

3. Increased concentrations of apoB-containing triglyceride-rich lipoprotein particles in patients with chronic renal failure;Attman;Miner Electrol Metab,1992

4. Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of apoA- and apoB-containing lipoprotein families;Alaupovic;Prog Lipid Res,1991

5. Triglyceride-rich and cholesterol-rich lipoproteins have a differential effect on mild to moderate/severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin;Hodis;Circulation,1994

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Research hotspots and future trends in lipid metabolism in chronic kidney disease: a bibliometric and visualization analysis from 2004 to 2023;Frontiers in Pharmacology;2024-09-03

2. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis;Cochrane Database of Systematic Reviews;2023-11-29

3. Expression of Caspase-3 in Circulating Innate Lymphoid Cells Subtypes Is Altered by Treatment with Metformin and Fluvastatin in High-Fat Diet Fed C57BL/6 Mice;Cells;2022-04-23

4. Effect of different types and dosages of statins on plasma lipoprotein(a) levels: A network meta-analysis;Pharmacological Research;2021-01

5. Current Understanding of the Relationship of HDL Composition, Structure and Function to Their Cardioprotective Properties in Chronic Kidney Disease;Biomolecules;2020-09-21